Paper36968288
Tumor microenvironment in glioblastoma: Current and emerging concepts.
Sharma P and 3 others. Neurooncol Adv, 2023. Cited by 335 papers, by iCite.
Cite this record
ConductScience Library. Tumor microenvironment in glioblastoma: Current and emerging concepts. Papers, record 36968288. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36968288
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA016672 | NCI NIH HHS | United States | P30CA016672 | PubMed | NIH RePORTER |
| R01 CA235673 | NCI NIH HHS | United States | R01CA235673 | PubMed | NIH RePORTER |
References175
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31159244 | A Microcavity Array-Based 4D Cell Culture Platform. | Bioengineering (Basel) | 2019 | https://conductscience.org/library/papers/31159244 | PubMed |
| 2 | 21833026 | Dysregulated pH: a perfect storm for cancer progression. | Nat Rev Cancer | 2011 | https://conductscience.org/library/papers/21833026 | PubMed |
| 3 | 34083447 | Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma. | Science | 2021 | https://conductscience.org/library/papers/34083447 | PubMed |
| 4 | 2684393 | Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. | Cancer Res | 1989 | https://conductscience.org/library/papers/2684393 | PubMed |
| 5 | 25510230 | Etomidate, propofol and diazepam potentiate GABA-evoked GABAA currents in a cell line derived from human glioblastoma. | Eur J Pharmacol | 2015 | https://conductscience.org/library/papers/25510230 | PubMed |
| 6 | 29605760 | Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering. | Curr Opin Immunol | 2018 | https://conductscience.org/library/papers/29605760 | PubMed |
| 7 | 36407765 | BDNF receptor TrkB as the mediator of the antidepressant drug action. | Front Mol Neurosci | 2022 | https://conductscience.org/library/papers/36407765 | PubMed |
| 8 | 29096244 | Neuronal activity in the glioma microenvironment. | Curr Opin Neurobiol | 2017 | https://conductscience.org/library/papers/29096244 | PubMed |
| 9 | 26728094 | Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames. | Nat Commun | 2016 | https://conductscience.org/library/papers/26728094 | PubMed |
| 10 | 31974491 | Nerves in cancer. | Nat Rev Cancer | 2020 | https://conductscience.org/library/papers/31974491 | PubMed |
| 11 | 32500020 | Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment. | Front Oncol | 2020 | https://conductscience.org/library/papers/32500020 | PubMed |
| 12 | 30420973 | CAR T cells targeting αvβ3 integrin are effective against advanced cancer in preclinical models. | Adv Cell Gene Ther | 2018 | https://conductscience.org/library/papers/30420973 | PubMed |
| 13 | 6384151 | Histochemical localization of primary and secondary alcohol dehydrogenases in whole-body, freeze-dried sections of mice. | Histochem J | 1984 | https://conductscience.org/library/papers/6384151 | PubMed |
| 14 | 28872113 | Organotypic Hippocampal Slice Cultures As a Model to Study Neuroprotection and Invasiveness of Tumor Cells. | J Vis Exp | 2017 | https://conductscience.org/library/papers/28872113 | PubMed |
| 15 | 33498369 | Beyond the Warburg Effect: Oxidative and Glycolytic Phenotypes Coexist within the Metabolic Heterogeneity of Glioblastoma. | Cells | 2021 | https://conductscience.org/library/papers/33498369 | PubMed |
| 16 | 26771115 | The Emerging Hallmarks of Cancer Metabolism. | Cell Metab | 2016 | https://conductscience.org/library/papers/26771115 | PubMed |
| 17 | 32302564 | Roadmap for the Emerging Field of Cancer Neuroscience. | Cell | 2020 | https://conductscience.org/library/papers/32302564 | PubMed |
| 19 | 11703458 | GABA(A)-receptor expression in glioma cells is triggered by contact with neuronal cells. | Eur J Neurosci | 2001 | https://conductscience.org/library/papers/11703458 | PubMed |
| 20 | 19477431 | Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment. | Cancer Cell | 2009 | https://conductscience.org/library/papers/19477431 | PubMed |
| 21 | 28029927 | Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy. | N Engl J Med | 2016 | https://conductscience.org/library/papers/28029927 | PubMed |
Cited by270
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 335 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42989284 | IFN-γ signaling drives multiple immunosuppressive pathways and poor clinical outcome in glioblastoma. | BMC Med | 2026 | https://conductscience.org/library/papers/42989284 | PubMed |
| 42940022 | Cross-Cancer Characterization of CAMK2A Reveals Its Favorable Prognostic Association and Neuronal Signature Enrichment in Glioma. | Biomedicines | 2026 | https://conductscience.org/library/papers/42940022 | PubMed |
| 42935925 | Clinical-scale manufacturing of CD137+ enriched tumor-reactive T cells for glioblastoma in the CliniMACS Prodigy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42935925 | PubMed |
| 42931532 | Effects of Sodin 5 on the Proliferation and Migration of Human Glioblastoma Cells. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/42931532 | PubMed |
| 42930186 | Translational Challenges and Strategies for Antibody Therapeutics in Glioblastoma. | Curr Oncol | 2026 | https://conductscience.org/library/papers/42930186 | PubMed |
| 42889017 | Salidroside inhibits glioma cell migration and proliferation through CYP2E1-neuroglobin-cytochrome c mediated redox axis. | Front Oncol | 2026 | https://conductscience.org/library/papers/42889017 | PubMed |
| 42848171 | Breaking adaptive oncogenic resistance in glioblastoma via targeting the EGFR-STAT3 axis. | Med Oncol | 2026 | https://conductscience.org/library/papers/42848171 | PubMed |
| 42824982 | Receptor tyrosine kinase targeted therapies in glioblastoma: a systematic review. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42824982 | PubMed |
| 42794597 | Ion Channel-Targeting Modulators in Glioma: Pharmacological Advances and Therapeutic Perspectives. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794597 | PubMed |
| 42686986 | NatD promotes glioblastoma progression through epigenetic activation of FGFR4 signalling. | Exp Mol Med | 2026 | https://conductscience.org/library/papers/42686986 | PubMed |
| 42683315 | The ERK MAPK pathway in mesenchymal glioblastoma: tumorigenesis, microenvironmental reprogramming, and the therapeutic promise of RAS(ON) multi-selective inhibition. | Front Mol Neurosci | 2026 | https://conductscience.org/library/papers/42683315 | PubMed |
| 42681467 | GeoMx Spatial Transcriptomics for Comprehensive Glioblastoma Molecular Profiling. | Methods Mol Biol | 2026 | https://conductscience.org/library/papers/42681467 | PubMed |
| 42658866 | First cell-patterning of primary, patient-derived mesenchymal glioblastoma brain cancer cells on parylene-C/SiO2 substrates. | PLoS One | 2026 | https://conductscience.org/library/papers/42658866 | PubMed |
| 42657075 | Mimicking tumor hypoxia in a glioblastoma-on-a-chip. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42657075 | PubMed |
| 42653450 | The Invasive Margin of Glioblastoma as a Molecular Ecosystem: Spatial Heterogeneity, Tumor-Host Interactions, and Therapeutic Opportunities. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653450 | PubMed |
| 42622966 | Crosslink Between Neuroinflammation and Oxidative/Nitrosative Status in the Glioblastoma Tumor Microenvironment: Prognostic and Theranostic Impact. | J Neuroimmune Pharmacol | 2026 | https://conductscience.org/library/papers/42622966 | PubMed |
| 42585180 | Targeting telomeres in brain vasculature does not impede initiation and progression of glioblastoma. | PLoS One | 2026 | https://conductscience.org/library/papers/42585180 | PubMed |
| 42582421 | PET-based Radiomics Analysis for Predicting Prognosis and Differentiation Treatment-Related Changes in Glioma: A Systematic Review. | J Biomed Phys Eng | 2026 | https://conductscience.org/library/papers/42582421 | PubMed |
| 42564003 | Prediction of MGMT promoter methylation in glioblastoma and grade 4 astrocytoma using fluid-suppressed chemical exchange saturation transfer MRI and machine learning-based segmentation. | Front Oncol | 2026 | https://conductscience.org/library/papers/42564003 | PubMed |
| 42509750 | Metabolic Reprogramming and Neurotransmitter Signaling Co-Option in the Glioma Immune Microenvironment: Dual-Axis Regulation of Immunosuppression. | Biomolecules | 2026 | https://conductscience.org/library/papers/42509750 | PubMed |
Genes51
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36968288
GET https://conductscience.org/api/papers/v1/36968288/references?page=2